Back to User profile » Dr Bin-Yan Zhong
Papers published by Dr Bin-Yan Zhong:
Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis
Xu XY, Wang Z, Liu CY, Wu HD, Hu ZX, Lin YY, Zhang S, Shen J, Zhong BY, Zhu XL
Journal of Hepatocellular Carcinoma 2024, 11:2019-2032
Published Date: 22 October 2024
The Value of Neutrophil-to-Lymphocyte Ratio in Predicting Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement
Tang HH, Zhou LF, Wang CX, Zha Y, Fan C, Zhong BY, Zhu XL, Wang WD
Journal of Inflammation Research 2024, 17:5211-5221
Published Date: 1 August 2024
Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy
Hu ZX, Xu XY, Wang Z, Huang JT, Li WC, Zhang S, Shen J, Zhong BY, Zhu XL
Journal of Hepatocellular Carcinoma 2023, 10:2073-2082
Published Date: 21 November 2023
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
Jiang JQ, Huang JT, Zhong BY, Wang WD, Sun JH, Wang Q, Ding WB, Ni CF, Zhu XL
Journal of Hepatocellular Carcinoma 2023, 10:1629-1638
Published Date: 26 September 2023
Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
Huang JT, Zhong BY, Jiang N, Li WC, Zhang S, Yin Y, Yang J, Shen J, Wang WS, Zhu XL
Journal of Hepatocellular Carcinoma 2022, 9:1217-1228
Published Date: 30 November 2022